Combination treatment of cancer with cetuximab and tetrac

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9180107
APP PUB NO 20100255108A1
SERIAL NO

12751375

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided herein are compositions and methods for treating cancer by increasing the inhibitory effect of cetuximab on HIF1α expression by administering cetuximab in combination with anti-angiogenic thyroid hormone analogs such as tetrac or triac.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • NANOPHARMACEUTICALS LLC

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Davis, Faith B West Sand Lake, US 12 376
Davis, Paul J West Sand Lake, US 46 1128
Lin, Hung-Yun Schenectady, US 6 63
Mousa, Shaker A Wynantskill, US 73 862

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 10, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00